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Available online 28 April 2016Conﬂicting results have been reported concerning a relationship between smoking and serumPTH. Our study ob-
jective was to examine whether smoking was associated with serum PTH independent of correlates of PTH
among young adults, and explore potential mechanisms.
This was a cross-sectional study of healthy individuals, 24–36 years old, examined during 1992 through 1993 in
California, USA (a subset of Coronary Artery Risk Development in Young Adults study).
Linear regressionwas used to obtain adjustedmeans of PTH according to smoking habit (current, former, never).
Biomarkers for calcium metabolism and bone turnover (including serum concentrations of osteocalcin, bone-
speciﬁc alkaline phosphatase, and 24-hour urinary excretion of calcium) and bonemineral densitywere similarly
compared by smoking.
376 participants were analyzed (171 women, 181 black). Over half reported never smoking.We observed lower
PTH in current smokers compared to non-smokers and found no evidence of an interaction by race and sex. PTH
was lowest in current smokers, intermediate in former smokers, and highest in never smokers (geometric mean
PTH: 23.6, 26.7, 27.4 pg/mL, respectively: P for trend, 0.006) after adjusting for potential confounders including
calcium intake. Among the biomarkers, serum osteocalcin concentration and 24-hour urinary excretion of calci-
um were lowest in current smokers. We observed no smoking-related difference in bone mineral density.
In this community-based sample of young adult men and women, smoking was associated with signiﬁcantly
lower PTH concentration. The mechanism and clinical implication of the ﬁnding, however, remains uncertain.





Smoking is generally associatedwith lower concentration of vitamin
D, lower bone mineral density and increased risk of fracture in the el-
derly. Therefore, a compensatory increase in parathyroid hormoneDIA, Coronary Artery Risk
5OHD, 25-hydroxyvitamin D;
ciﬁc alkaline phosphatase; U-
ized for urinary excretion of cre-
d Community Health, School of
e Building, 1300 S. 2nd Street,
a-med.ac.jp (A. Fujiyoshi).
. This is an open access article under(PTH)may be expected (Jorde et al., 2005). However, conﬂicting results
have been reported in the literature on the relation between smoking
and PTH. While some studies reported higher PTH among smokers
(i.e. expected direction) (Rapuri et al., 2000; Szulc et al., 2002;
Ortego-Centeno et al., 1997), others have reported lower PTH concen-
tration among smokers (Mellstrom et al., 1993; Landin-Wilhelmsen
et al., 1995; Brot et al., 1999; Need et al., 2002). One of the largest
population-based observational studies documented this unexpected
ﬁnding cross-sectionally (Jorde et al., 2005), yet the underlying mecha-
nism and clinical implication of the ﬁnding remains to be elucidated.
In this study, we investigated a cross-sectional relationship between
smoking habits and concentration of PTH using a population-based
sample of men and women in the USA. The primary aim was to investi-
gate whether PTH concentration differs among current, former andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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consistencies in the literature, we did not have a hypothesis about the
direction of the PTH and smoking association. The secondary aim was
to explore potentialmechanisms using biologicalmarkers related to cal-
ciummetabolism and bone turnover according to smoking habit.
2. Methods
2.1. Study population
We studied a subgroup of participants of the Coronary Artery Risk
Development in Young Adults (CARDIA) study. A detailed description
of CARDIA has been published elsewhere (Friedman et al., 1988). In
brief, CARDIA is a cohort study of the evolution of cardiovascular risk
among young adults, conducted since 1985. The participants for the
present studywere enrolled in the CARDIA study in the Oakland Clinical
Center, California, who were returning for their fourth examination
from June 1992 through May 1993 to participate in an ancillary study
of bone mineral homeostasis (Bikle et al., 1999). All subjects, aged
24–36 years, were in good health and had a serum creatinine level
b1.6 mg/dL and a serum calcium level ranging from 8.8 to 10.3 mg/dL.
Within the year before the examination, all women menstruated regu-
larly, were not taking oral contraceptive agents, and had not been preg-
nant ≥10 weeks or breastfeeding. Subjects with medical conditions or
taking medications known to alter calcium homeostasis were excluded
from the study (Bikle et al., 1999). The data were collected with written
informed consent and with approval of the local Institutional Review
Board. Of 402 ancillary study participants, we included those partici-
pants with no missing variables directly relevant to the primary aim
(i.e. to examine association between smoking and PTH). We excluded
those who gave unrealistic estimate of energy intake (⟨800 or
⟩8000 kcal/day in men; ⟨600 or ⟩6000 kcal/day in women), leaving 376
participants for analysis.
2.2. Measurement
Demographic information was obtained using standardized ques-
tionnaires. Weight was measured on a balance beam scale. Height was
measured using a vertically mounted metal centimeter ruler. Body
mass index (BMI) was computed as weight (kg) divided by square of
height (m). At examination, fasting blood including creatinine, phos-
phate and calcium (collected between 8:00 and 11:00 AM) and 24-
hour urine samples were obtained for analysis using routine laboratory
procedures and an automated chemistry analyzer (Bikle et al., 1999).
PTH and other biomarkers weremeasured on stored samples 3 years
after study completion (Bikle et al., 1999; Ettinger et al., 1997). PTH was
measured using a 2-site immunoradiometric assay that detects only in-
tact PTH (i.e. biologically active 84-amino-acid peptide) (Nussbaum
et al., 1987). Serum 25-hydroxyvitamin D (25OHD) was measured by
RIA in the Calciotropic Hormone Reference Laboratory, University of Cal-
ifornia, San Francisco. Serum 1,25-dihydroxyvitamin D (1,25(OH)2D)
was measured by a competitive protein-binding assay using the vitamin
D receptor present in calf thymus cytosol (Bikle et al., 1999). Osteocalcin
was measured using a mid-molecule–speciﬁc RIA for human osteocalcin
(Taylor et al., 1988). Bone-speciﬁc alkaline phosphatase (BAP) wasmea-
sured spectrophotometrically after heat inactivation (Farley et al., 1981).
Free pyridinoline cross-links in urine were measured using an ELISA de-
veloped by Metra Biosystems (Seyedin et al., 1993). The results of this
method were compared with that of direct assessment after HPLC puri-
ﬁcation (Black et al., 1988) for 20 subjects in each race and gender
group to verify the comparability of this method with that using HPLC
(r N 0.9 for all groups) before adopting this method for use in assessing
all subjects (Bikle et al., 1999). 24-hour urinary excretion of pyridinoline
was standardized for urinary excretion of creatinine (U-PYDcr) for
analysis.2.3. Assessment of lifestyle information
The usual diet was assessed by a diet history interview (CARDIA di-
etary history) in which food models and measuring cups and spoons
were used to estimate portion size. The previous month was used as a
frame of reference for estimating the usual intake. Intake of dietary cal-
ories and calcium were estimated according to the nutrient data base
developed by the Nutrition Coordinating Center at the University of
Minnesota. The estimate of calcium intake included supplemental
sources. Validity and reliability of the CARDIA dietary history has been
published elsewhere (Liu et al., 1994). Sun exposure time was assessed
by query for weekday and weekend separately and then calculated as
hours per week. The CARDIA physical activity history questionnaire
was used to quantify physical activity level, and scored accordingly
(physical activity score). The amount of time per week spent in leisure,
occupational, and household physical activity over the previous
12monthswas assessed.We estimated total physical activity expressed
in exercise units as a product of intensity and frequency. The validity
and reliability of the questionnaire was published elsewhere (Jacobs
et al., 1989).
Additionally, we examined bone mineral density (BMD) at various
sites according to smoking habit. Dual-energy x-ray absorptiometry
measurement of BMD for the whole body, total hip, left and right total
arms, and lumbar spinewas obtained by using a Hologic QDR 2000 den-
sitometer (Hologic, Inc.) in the array scanningmode, separately for each
area of the body (total hip, lumbar spine, and whole body). The total
arm was assessed using the whole-body scan (Fujiyoshi et al., 2013).
In vivo precision for BMD, based on repeated scans of 20 volunteers
done 1 to 6 weeks apart and expressed as a coefﬁcient of variation,
was 0.9% for whole-body BMD.
2.4. Statistical analysis
Weused linear regressionmodels to obtain adjusted PTH concentra-
tions according to smoking habits (Current, Former, and Never). Due to
skewed distributions, we log-transformed the following variables in our
statistical models: PTH, 25OHD, BAP, U-PYDcr and calcium intake in
density. When any of these variables was used as a dependent variable,
we back-transformed the results to present the adjusted geometric
means for ease of interpretation. For the main analyses, we constructed
the following models: Model 1 adjusted for age (years), race (Black,
White), sex, and education (up to 15 years, 16 years or greater).
Model 2 adjusted additionally for calcium intake in density (mg/
1000 kcal/day, supplements included, log-transformed), serum concen-
trations of 25OHD (ng/mL, log-transformed), creatinine (mg/dL), and
season (Jan–Mar, Apr–Jun, July–Sep, and Oct–Dec) of blood draw.
Model 3 further adjusted for physical activity score and sun-exposure
time (hours/week). Model 4 further adjusted for body mass index
(kg/m2).
For each sex and race/ethnicity group, we observed that PTH con-
centrations tended to be high in never smokers, and low in current
smokers, then we tested interaction by sex or race/ethnicity on the
association of smoking and PTH by inserting a product term in the
models. All the interaction terms were non-signiﬁcant throughout
themodels. Therefore, we presented sex- and race-combined results.
We tested linear trend of PTH across the smoking habits by using an
ordinal variable (0=never, 1= former, and 2= current smoker). As
sensitivity analyses, we repeated the main analyses replacing calci-
um density in the models with either a) calcium density excluding
supplemental source (i.e. dietary source of calcium only) or,
b) absolute amount of calcium intake (mg/day) or, c) serum calcium
concentration (mg/dL).
For the secondary aim, we estimated the adjusted means of the
following biological markers: serum phosphate [mmol/L], serum
1,25(OH)2D [nmol/L], 24-hour urinary calcium [mmol/day], fractional
excretion of calcium (FEca, also known as calcium/creatinine clearance
Table 2
Crude and adjusted means of PTH (pg/mL) according to smoking habit.










26.6 29.8 29.0 – – –
Crude, geometric
means
24.3 27.4 26.9 0.095 0.082 0.055
Model 1 23.5 26.8 27.4 0.008 0.051 0.005
Model 2 23.6 26.5 27.4 0.006 0.068 0.004
Model 3 23.5 26.6 27.4 0.005 0.051 0.003
Model 4 23.6 26.7 27.4 0.006 0.054 0.004
Trend Ps were calculated using smoking status as an ordinal variable (0=never smoker, 1
= former smoker, 2 = current smoker).
Values were all geometric means unless otherwise speciﬁed. Model 1 adjusted for age
(years), race (Black, White), sex, education (up to 15 years, 16 years or greater). Model
2 adjusted for calcium intake in energy density (mg/1000 kcal/day, log-transformed),
serum level of 25OHD (ng/mL, log-transformed), serum level of creatinine (mg/dL), and
season (Jan–Mar, Apr–Jun, July–Sep, and Oct–Dec) in addition toModel 1. Model 3 adjust-
ed for physical activity score and sun-exposure time (hours/week) in addition toModel 2.
Model 4 adjusted for body mass index (kg/m2) in addition to Model 3.
a There was no statistically signiﬁcant difference between former smokers and never
smokers in all models.
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clearance of creatinine or:
Uca=Pcað Þ  Pcr=Ucrð Þ:
where Uca and Ucr are the 24-hour urinary excretions of calcium or cre-
atinine, and Pca and Pcr are the plasma concentrations of calcium and
creatinine (Bikle et al., 1999). For bone-turnover markers, we used
serum osteocalcin [ng/mL], serum BAP [IU/L], and U-PYDcr [micro-
mole/mmol creatinine]. Osteocalcin and BAP are markers for bone for-
mation, whereas U-PYDcr is a marker for bone resorption. We used
the same sets of adjusting covariates as in the main analysis except for
FEca in that serum creatinine was excluded from the models. This was
because FEca itself is standardized by serum creatinine. Lastly, we com-
pared adjusted means of the following BMDs according to smoking
habit: whole body, arms (average of left and right), lumbar spine, and
total hip.
All the statistical tests were considered to be signiﬁcant when P
values were b0.05. Statistical analysis was conducted by SAS version
9.4 (SAS Institute).
3. Results
We analyzed 376 participants (171 women, 181 black, age 24–
36 years). Demographics of the participants according to smoking
habit for each sex and race/ethnicity were given in Table 1.
In all sex-, race/ethnicity- groups, more than half of the participants
(56–72%) reported never smoking. Over a quarter of black men (25.8%)
and black women (26.1%) reported current smoking, whereas 10.7% of
White men and 15.7% of White women did so. Across the sex and
race/ethnicity strata, current smokers tended to have greater sun-
exposure hours and higher BMI (with exception for calcium intake in
white women and BMI for black men), and tended to have fewerTable 1
Demographics of participants according to smoking habit.
No. Black men (N= 93) Black wo
Current Former Never Current
24 9 60 23
Age, years 30.8 32.0 30.4 30.4
Education, years 14 13 15 13
Body mass index, kg/m2 25.0 24.9 27.0 29.2
Energy intake, kcal/day 4140 4371 3304 2479
Calcium intakea, mg/day 1614 1263 1303 879
Calcium intakea in density, mg/1000 kcal/day 410 290 410 370
Physical activity score 498 428 533 239
Sun exposure time, hours/week 32.5 29.7 27.3 27.1
Calcium (serum), mg/dL 9.5 9.5 9.6 9.3
25OHD (serum), ng/mL 32.4 35.3 32.7 20.4
Creatinine (serum), mg/dL 0.99 1.04 1.03 0.79
Biomarkers related to calcium-metabolism
Phosphate (serum), mg/dL 3.13 2.96 3.18 3.38
1,25(OH)2D (serum), pg/mL 46.1 45.9 43.8 45.3
24-hour urinary Ca, mmol/day 2.64 4.56 4.15 2.19
Fraction excretion of calcium (×100) 0.74 0.86 0.85 0.57
Bone turnover marker
Osteocalcin (serum), ng/mL 11.7 12.5 14.6 9.8
BAP (serum), U/L 9.2 7.6 9.8 7.2
U-PYDcr, μmol/mmol creatinine 24.9 23.5 24.5 34.3
Bone mineral density, g/cm2
Whole body 1.27 1.32 1.30 1.17
Lumbar spine 1.14 1.20 1.13 1.16
Total hip 1.16 1.22 1.19 1.05
Arms (average of right and left) 0.98 1.02 1.02 0.81
Parathyroid hormone, pg/mL 24.4 22.2 25.7 30.5
Abbreviations: 25OHD, 25-hydroxyvitamin D; 1,25(OH)2D, 1,25-dihydroxyvitamin D; 24-hour
U-PYDcr: urinary excretion of pyridinoline corrected with urinary excretion of creatinine.
a Calcium intake included supplemental source.education years. We observed no clear patterns by smoking habit for
serum concentrations of calcium, 25OHD and creatinine across the
strata.
Crude (arithmetic or geometric) and adjusted means of PTH accord-
ing to smoking habit were shown in Table 2. Current smokers tended to
have lower PTH concentrations compared to never smokers. With ad-
justment for basic demographics in Model 1 (age, race, sex, and educa-
tion), a signiﬁcant trend was observed such that PTH concentrations
were lowest in current smokers and highest in never smokers. Thismen (N= 88) White men (N= 112) White women (N= 83)
Former Never Current Former Never Current Former Never
16 49 12 19 81 13 20 50
31.1 31.1 31.1 30.8 31.4 29.7 33.1 31.8
14 14 13 15 16 13 15 17
26.9 28.6 26.6 26.1 25.3 26.6 26.3 23.2
2066 2107 3527 3241 3199 2604 2209 2446
751 828 1506 1471 1449 1304 1391 1320
380 400 430 440 440 510 600 560
253 298 347 504 423 359 312 387
15.8 23.8 18.1 17.8 17.0 16.3 14.3 14.4
9.4 9.3 9.7 9.5 9.6 9.4 9.3 9.4
19.2 23.6 37.5 38.2 38.6 39.6 36.1 36.6
0.75 0.80 0.89 0.92 0.95 0.78 0.74 0.78
3.27 3.34 2.78 3.07 2.89 2.97 3.03 3.36
49.0 43.1 40.3 38.0 39.8 38.9 39.7 37.9
2.49 2.66 4.66 5.64 5.02 3.78 3.85 3.94
0.58 0.71 1.07 1.18 1.06 0.93 0.91 1.09
10.8 9.6 13.3 14.8 14.9 10.8 12.9 13.4
8.2 8.4 9.0 9.9 8.5 7.1 7.4 6.7
41.2 37.6 28.8 27.4 26.9 33.6 37.3 39.2
1.15 1.16 1.16 1.19 1.18 1.11 1.11 1.08
1.08 1.13 1.02 1.08 1.02 1.03 1.05 1.04
0.98 1.04 1.05 1.06 1.03 0.97 0.96 0.95
0.79 0.81 0.94 0.95 0.95 0.80 0.79 0.77
37.8 38.4 26.0 25.4 26.9 24.3 31.2 27.0
urinary Ca, 24-hour urinary excretion of calcium; BAP: bone-speciﬁc alkaline phosphatase;
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source of calcium intake did not change the overall results (data not
shown). Replacing energy-adjusted calcium intake with either absolute
amount of calcium intake (mg/day) or serum calcium concentration
(mg/dL) in the models yielded similar results (data not shown). In sub-
group analysis restricted to current smokers (n= 72), PTH concentra-
tion was not associated with number of cigarettes smoked per day
(data not shown). Since the participants were not directly queried on
duration and amount of cigarette smoking in the past, we did not test
a dose-response relationship using pack-years of smoking. Since
smoking is often associated with lower BMI, and serum PTH is associat-
ed with higher BMI (Kontogeorgos et al., 2015), there was a possibility
of residual confounding by BMI on the observed association between
smoking and PTH. To address this possibility, we have repeated the
analyses stratiﬁed bymedian BMI (25.10 kg/m2) usingModel 3. Results
were consistent with themain onewith no statistical evidence of inter-
action by BMI (Table 3).
Table 4 summarized results of markers related to calcium metabo-
lismand bone turnover according to smokinghabit.We observed signif-
icantly lower 24-hour urinary calcium excretion in current smokers
compared to non-current smokers, with a similar pattern for FEca.
Among bone turnover makers, osteocalcin was lower in current than
non-current smokers with a signiﬁcant linear trend. Serum concentra-
tions of phosphate, 1,25(OH)2D, BAP, and U-PYDcr had no clear differ-
ence among the smoking groups.
We observed no signiﬁcant difference in any BMD site across
smoking categories after adjustment for sex and race with or without
other covariates added (data not shown).
4. Discussion
In this generally healthy sample of black andwhite, young adultmen
andwomen, we observed that PTH concentrationwas lowest in current
smokers, followed by former smokers, and highest in never smokers.
This relationship appeared to be independent of factors that affect PTH
concentration, such as dietary calcium intake and serum 25OH vitamin
D concentration (Steingrimsdottir et al., 2005).
Smoking is generally associated with reduced bone density, and re-
duced concentrations of vitamin D among elderly populations. There-
fore, a compensatory increase in PTH may be expected in smokers
(Jorde et al., 2005). However, studies on PTH concentration comparing
smoker/non-smoker are conﬂicting. Some studies showed lowerTable 3
Adjusted means of PTH according to smoking habit stratiﬁed by median BMI.








21.4 25.5 25.8 0.042 0.765




25.9 26.9 29.1 0.071
* Median BMI was 25.10 kg/m2. Participants were fairly evenly distributed bymedian BMI
across the group of smoking habits, sex, and race/ethnicity. Percentage (%) of the partici-
pants with BMI b median for each group was as follows: never (50.4), former (56.3),
and current (43.1) smoker, men (48.3), women (52.1), black (40.3), white (59.0).
†Values were geometric means adjusted for the same set of covariates as Model 3 in the
text as follows: age (years), race (Black, White), sex, education (up to 15 years, 16 years
or greater), calcium intake in energy density (mg/1000 kcal/day, log-transformed),
serum level of 25OHD (ng/mL, log-transformed), serum level of creatinine (mg/dL), sea-
son (Jan–Mar, Apr–Jun, July–Sep, and Oct–Dec), physical activity score and sun-exposure
time (hours/week).
To obtain P-values, smoking status was treated as an ordinal variable (0= never smoker,
1 = former smoker, 2 = current smoker). P for interaction by median BMI was obtained
by inserting a product term (smoking habit x median BMI) in the model.(Jorde et al., 2005; Mellstrom et al., 1993; Landin-Wilhelmsen et al.,
1995; Brot et al., 1999; Need et al., 2002), but others reported higher
PTH concentrations in smokers (Rapuri et al., 2000; Szulc et al., 2002;
Ortego-Centeno et al., 1997). One of the largest population studies on
this question examined 7896 men and women in Norway and found
lower PTH concentrations in smokers compared to non-smokers re-
gardless of age, sex, BMI, and serum creatinine concentration (the ﬁfth
Tromsø study) (Jorde et al., 2005). Our ﬁnding of lower PTH in smokers
is consistent with the Tromsø study, and the observed relationship in
our study was robust to adjustment for other factors associated with
PTH including sun-exposure time, serum 25OHD concentrations.
Studies reporting higher PTH in current smokers, the opposite ﬁnd-
ing to ours, appear to have serious limitations in generalizing their re-
sults. In a study of healthy men in Spain, Ortego-Centeno and
colleagues reported higher PTH in smokers (n = 15) than non-
smokers (n= 17). However, the difference was not statistically signiﬁ-
cant (P-value not provided) and the sample size was small.(Ortego-
Centeno et al., 1997) Szulc and colleagues reported statistically
signiﬁcantly higher PTH concentration in French current smokers
(n=35) compared tonever smokers (n=93) (Szulc et al., 2002). How-
ever, this comparison was based on subgroup of individuals who
weighed b75 kg. Including all their participants (719 men, aged 51–
85 years), the results appeared to be consistent with our ﬁndings, al-
though not statistically signiﬁcant (Szulc et al., 2002). In a study of
489 elderly women (65–77 years) in the USA, Rapuri and colleagues
showed higher PTH in heavy smokers than non-smokers. However,
the difference was not statistically signiﬁcant, nor was it adjusted for
serum 25OHD and other possible confounders (Rapuri et al., 2000).
Potential mechanisms have been proposed to explain lower PTH in
smokers such as direct toxic effect of smoking on the parathyroid
cells, enhanced degradation or suppressed secretion of PTH by smoking
(Jorde et al., 2005; Brot et al., 1999; Need et al., 2002). Among those,
Need and colleagues hypothesized that direct impairment of osteoblast
function by smoking was likely to result in a slight increase in serum
ionized calcium, leading to suppression of PTH (Need et al., 2002). Our
ﬁnding of lower osteocalcin (bone formation marker) in current
smokers than non-current smokers is consistent with this hypothesis
and consistent with another study on healthy perimenopausal women
(Brot et al., 1999) although the other bone formation marker, BAP, did
not show a signiﬁcant pattern in our study and we did not have vari-
ables to estimate serum ionized calcium. We also observed lower 24-
hour urinary calcium excretion in current smokers than non-smokers,
which seems consistent with the ﬁfth Tromsø study reporting a lower
but non-signiﬁcant 24-hour urinary calcium excretion in smokers
(n=54) compared to non-smokers (n=151) based on the small sub-
groupwhounderwent biochemical assessments (Jorde et al., 2005). The
lower calcium excretion in current smokers could be due to lower oste-
oclast function in smokers and a response to low PTH levels. These ac-
tions allow for the maintenance calcium balance between formation
and reabsorption frombone. Understanding themechanism and clinical
implication of the ﬁnding will require further study.
In comparing BMDat various sites,we observed no signiﬁcant differ-
ence according to smoking habit in the study sample. Although smoking
is a known risk factor for osteoporosis and reduced BMD in the elderly, it
may require longer exposure time and/or a larger sample size for ad-
verse effect of smoking on BMD to be evident given the relatively
young age (24–36 years) of our study participants, the age range at
which bone mass reaches its peak (Davies et al., 2005). Alternate
methods of modeling exposure to smoking such as use of pack-year
might have led to different ﬁndings (Callreus et al., 2013). However,
we did not model exposure to smoking using pack-year given limita-
tions in the method for querying smoking history in CARDIA.
A few studies have explicitly reported PTH concentration among for-
mer smokers relative to those in current and never smokers. The ﬁfth
Tromsø study reported similar concentration between former and
never smokers, higher than current smokers. However, they took into
Table 4
Adjusted means of factors related to calcium metabolism and bone turnover.
Smoking habit Trend P P for pairwise comparison
Current Former Never Current vs former Current vs never
Phosphate, serum, mg/dL, 3.10 3.10 3.16 0.291 0.989 0.365
1,25(OH)2D, serum, pg/mL 42.4 43.2 41.3 0.332 0.677 0.476
24-h urinary Ca, mmol/day 3.22 4.18 4.03 0.042 0.024 0.018
FEca (×100)a 0.80 0.90 0.93 0.082 0.287 0.074
Osteocalcin, serum, ng/mL 11.5 13.3 13.2 0.019 0.030 0.009
BAPb, serum, IU/L 7.1 8.0 7.8 0.126 0.065 0.068
U-PYDcrb, μmol/mmol creatinine 28.6 29.7 29.5 0.550 0.462 0.472
With exception for FEca, themean valueswere adjusted for the same covariates asModel 4 in themain analyses as follows: age (years), race (Black,White), sex, education (up to 15 years,
16 years or greater), energy density of calcium intake (mg/1000 kcal/day, log-transformed), levels of 25OHD (ng/mL, log-transformed) and creatinine (mg/dL), season (Jan–Mar, Apr–Jun,
July–Sep, andOct–Dec), physical activity score, sun-exposure time (hours/week) and bodymass index (kg/m2). Trend Ps were calculated using smoking status as an ordinal variable (0=
never smoker, 1 = former smoker, 2 = current smoker).
Abbreviations: 1,25(OH)2D: 1,25-dihydroxyvitamin D; 24-hour urinary Ca: 24-hour urinary excretion of calcium; FEca: factional excretion of calcium; U-PYDcr: urinary excretion of
pyridinoline corrected with urinary excretion of creatinine; BAP: bone-speciﬁc alkaline phosphatase.
a For FEca, serum creatinine concentration was excluded from the model adjustment because this measure is standardized with creatinine concentration.
b Values were given in geometric means.
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counting for recent quitters. In a study of 405 postmenopausal
women, PTH concentrations were lowest in current, intermediate in
former, and highest in never smokers (Need et al., 2002), which is con-
sistentwith ourﬁnding. The association between smoking and PTHmay
persist for a while, when quitting, then decline over time. To better clar-
ify the relationship in future, a large-scale longitudinal study with re-
peated assessment for smoking and PTH is warranted. Such study
should be able to examinenot onlywhether the association persists lon-
gitudinally, but also dose-response of smoking and length of smoking
cessation (former smokers) in relation to PTH.
Limitations need to be considered in interpreting our ﬁndings. First,
the studywas cross-sectional in design,making it difﬁcult to prove tem-
poral relationships between exposure (smoking) and outcome (PTH)
althoughwe believe it is uncommon for individuals to quit or not to ini-
tiate smoking due to high PTH concentration. Second, given the obser-
vational nature of the study, we cannot refute the possibility of
residual or unmeasured confounding on the results. Third, our data
were collected and measured in the 1990s. Some measurements used
in the study may differ from the ones more recently used. Strengths of
our study include availability of important factors associated with PTH
enabling us to control for potential confounders including serum
25OHDand creatinine, calcium intake, bodymass index andphysical ac-
tivity. Likewise, various markers of calciummetabolism and bone turn-
over allowed us to explore potential mechanism of the ﬁndings.
Another strength is enrollment of black and white men and women
aged 24 to 36 years, making the results likely generalizable to healthy
young adults.
5. Conclusions
In summary, we found signiﬁcantly lower concentration of PTH in
current smokers, followed by former smokers, compared to never
smokers in a population-based sample of young adult men and
women. The relation was not explained by determinants of PTH such
as dietary calcium intake and serum vitamin D. Additionally, we ob-
served low serum osteocalcin and low 24-hour urinary calcium excre-
tion in current smokers but no difference in BMD according to
smoking habits. The clinical implication and potential mechanism of
the ﬁndings, however, remain unclear, warranting further research.
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